Skip to content

Leveraging mHealth and Peers to Engage African- Americans and Latinxs in HIV Care (LEAN)

Leveraging mHealth and Peers to Engage African-Americans and Latinxs in HIV Care (LEAN)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03934437
Enrollment
451
Registered
2019-05-01
Start date
2020-02-10
Completion date
2024-03-30
Last updated
2024-11-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV/AIDS

Brief summary

This is a pragmatic randomized controlled study comparing existing linkage to care and retention (LTCR) services to an mHealth-enhanced linkage to care and retention (mLTCR) protocol.

Detailed description

Baltimore's HIV prevalence rate (586/100,000) is among the top 5 in metropolitan areas in the US, and disparities are profound. African Americans have an HIV prevalence that is 5 times higher than among whites, and account for 78% of all HIV cases. Latinxs also have a higher prevalence of HIV than whites and are at the highest risk for late HIV diagnosis among all racial/ethnic groups. In addition, HIV viral load suppression, which is the best predictor of long-term survival among HIV-infected patients, is substantially lower among minority populations in Baltimore. The overall goal of this proposal is to evaluate whether mHealth-enhanced Linkage to Care and Retention (mLTCR) can improve HIV outcomes among HIV-infected African Americans and Latinos compared to standard Linkage to Care and Retention (LTCR) programs. The mHealth-enhancement consists of two smartphone applications (app), one for patients and one for patient supporters (e.g. linkage officers, patient navigators, nurses, etc.), to help facilitate communication. Communication will focus on issues related to HIV care (e.g. appointment scheduling, transportation), as well as patient-directed requests. Using HIV surveillance data (e.g. unsuppressed HIV viral load), patient supporters will be automatically alerted if a patient has a high viral load and prompted to contact the patient. In addition to appointment reminders, patients will receive positive reinforcement behavioral text messages.

Interventions

BEHAVIORALmLTCR

mHealth-enhanced Linkage to Care and Retention

BEHAVIORALLTCR

Linkage and Retention Services (Standard-of-Care)

Sponsors

Patient-Centered Outcomes Research Institute
CollaboratorOTHER
Johns Hopkins University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ≥ 18 years of age * Ability to provide consent * Identified by BCHD Linkage protocol to be a new HIV diagnosis or HIV-infected and out of care * Identified by participating clinics as needing patient support services

Exclusion criteria

* Not able to provide consent.

Design outcomes

Primary

MeasureTime frameDescription
Participants With HIV Viral Load Suppression (Copies/cc)12 monthsViral Suppression defined as a viral load \< 200 copies/cc

Secondary

MeasureTime frameDescription
Participants Retained in Care12 monthsRetained in care based upon viral load, CD4, OR clinic visit reported in enhanced HIV/AIDS Reporting System (eHARS)

Countries

United States

Participant flow

Participants by arm

ArmCount
mLTCR
The mLTCR intervention consists of two smartphone applications (app), one for patients and one for patient supporters, to help facilitate communication. mLTCR: mHealth-enhanced Linkage to Care and Retention
223
LTCR
Existing linkage to care and retention (LTCR) services which are standard-of-care LTCR: Linkage and Retention Services (Standard-of-Care)
225
Total448

Baseline characteristics

CharacteristicmLTCRLTCRTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
13 Participants18 Participants31 Participants
Age, Categorical
Between 18 and 65 years
210 Participants207 Participants417 Participants
Age, Continuous45.1 years45.0 years45.1 years
HIV Viral Load Suppression (Copies/cc)
Detectable (>=200 copies/cc, poorly controlled)
93 Participants82 Participants175 Participants
HIV Viral Load Suppression (Copies/cc)
No VL (presumed poorly controlled)
18 Participants15 Participants33 Participants
HIV Viral Load Suppression (Copies/cc)
Undetectable (<200 copies/cc, well controlled)
112 Participants128 Participants240 Participants
Race (NIH/OMB)
American Indian or Alaska Native
2 Participants6 Participants8 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
173 Participants172 Participants345 Participants
Race (NIH/OMB)
More than one race
6 Participants5 Participants11 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
22 Participants25 Participants47 Participants
Race (NIH/OMB)
White
20 Participants17 Participants37 Participants
Region of Enrollment
United States
223 participants225 participants448 participants
Sex: Female, Male
Female
87 Participants73 Participants160 Participants
Sex: Female, Male
Male
136 Participants152 Participants288 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
9 / 22511 / 226
other
Total, other adverse events
0 / 2250 / 226
serious
Total, serious adverse events
0 / 2250 / 226

Outcome results

Primary

Participants With HIV Viral Load Suppression (Copies/cc)

Viral Suppression defined as a viral load \< 200 copies/cc

Time frame: 12 months

Population: Two participants withdrew from mLTCR; one participant withdrew from LTCR.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
mLTCRParticipants With HIV Viral Load Suppression (Copies/cc)Undetectable (<200 copies/cc, well controlled)114 Participants
mLTCRParticipants With HIV Viral Load Suppression (Copies/cc)Detectable (>=200 copies/cc, poorly controlled)38 Participants
mLTCRParticipants With HIV Viral Load Suppression (Copies/cc)No VL (presumed poorly controlled)71 Participants
LTCRParticipants With HIV Viral Load Suppression (Copies/cc)Undetectable (<200 copies/cc, well controlled)128 Participants
LTCRParticipants With HIV Viral Load Suppression (Copies/cc)Detectable (>=200 copies/cc, poorly controlled)32 Participants
LTCRParticipants With HIV Viral Load Suppression (Copies/cc)No VL (presumed poorly controlled)65 Participants
Secondary

Participants Retained in Care

Retained in care based upon viral load, CD4, OR clinic visit reported in enhanced HIV/AIDS Reporting System (eHARS)

Time frame: 12 months

Population: Two participants withdrew from mLTCR; one participant withdrew from LTCR.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
mLTCRParticipants Retained in Care152 Participants
LTCRParticipants Retained in Care160 Participants

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026